Mycoplasma pneumoniae pneumonia and respiratory failure in children
10.3760/cma.j.issn.2095-428X.2018.12.003
- VernacularTitle:儿童肺炎支原体肺炎与呼吸衰竭
- Author:
Wei XU
1
Author Information
1. 中国医科大学附属盛京医院小儿急诊急救内科
- Keywords:
Mycoplasma pneumoniae;
Pneumonia;
Child;
Respiratory failure;
Acute respiratory distress syn-drome;
Treatment
- From:
Chinese Journal of Applied Clinical Pediatrics
2018;33(12):887-891
- CountryChina
- Language:Chinese
-
Abstract:
Mycoplasma pneumoniae (MP)is one of the most common causes of community-acquired pneu-monia in children. The incidence of respiratory failure due to Mycoplasma pneumoniae pneumonia (MPP)is relatively rare despite the high prevalence of MP infection. Prevalence of respiratory failure was unsure in children,most of them presented with hypoxia or acute respiratory distress syndrome. Key clinical findings include cough,fever,and dyspnea along with diffuse abnormal findings in radiological examinations. Levels of inflammatory markers such as white blood cells and C-reactive protein are elevated. The exact pathogenesis of fulminant MPP remains unclear,radiological ima-ges usually showed bilateral infiltrates and pleural effusion commonly present in MPP cases with respiratory failure. Treatment options involve pairing the appropriate anti-mycoplasma agent with a corticosteroid which aimed at decrea-sing the hypersensitivity response,further research is necessary to determine the exact pathogenesis of MPP with respira-tory failure. Now,the most recent data in epidemiology,research situation,pathogenesis,clinical and X-ray presenta-tion,and treatment of respiratory failure with MPP are described.
